Home | Welcome to Contract Pharma   
Last Updated Monday, April 21 2014
Print RSS Feed

Trials & Filings

Kristin Brooks
January 23, 2014
Demonstrates statistically significant benefit  Read More »
Kristin Brooks
January 23, 2014
Reduces LDL-C in statin intolerant patients  Read More »
Kristin Brooks
January 23, 2014
To evaluate cyclophosphamide combination in pediatric tumors  Read More »
Kristin Brooks
January 17, 2014
Authorization follows accelerated EMA assessment  Read More »
Gil Roth
January 15, 2014
Camargo conducts abuse-deterrence study under 505(b)2  Read More »
Gil Roth
January 15, 2014
Otrexup approved in October 2013 for RA, pJIA  Read More »
Gil Roth
January 15, 2014
12-week program continues with CKD patients  Read More »
Gil Roth
January 15, 2014
EACRI to test galectin-3 inhibitor with Yervoy in metastatic melanoma  Read More »
Gil Roth
January 15, 2014
Veliparib to be added to carboplatin in Ph III trial  Read More »
Gil Roth
January 14, 2014
Tests CNP analog against achondoplasia in children  Read More »
Gil Roth
January 14, 2014
Preclinical tests in mice lead to Ph II plans  Read More »
Gil Roth
January 14, 2014
Testing pharmacokinetics of novel pain-blocker  Read More »
Gil Roth
January 14, 2014
Ph II study to involve 30 patients   Read More »
Gil Roth
January 14, 2014
Tests pracinostat in patients failing HMA therapy  Read More »
Gil Roth
January 14, 2014
FDA recognizes need for dabrafenib treatment  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On